Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.930
-0.310 (-7.31%)
At close: Jan 30, 2025, 4:00 PM
3.998
+0.068 (1.74%)
After-hours: Jan 30, 2025, 5:22 PM EST
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $19.00 million as of January 30, 2025. Its market cap has increased by 99.77% in one year.
Market Cap
19.00M
Enterprise Value
15.83M
1-Year Change
99.77%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $19.00M, a decrease of -81.64%. That is a compound annual growth rate of -33.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 20.50M | -1.17% |
| Dec 31, 2024 | 20.74M | 39.27% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.84B |
| UnitedHealth Group | 499.24B |
| Novo Nordisk | 378.98B |
| Johnson & Johnson | 362.06B |
| AbbVie | 308.91B |
| Merck & Co. | 246.51B |
| Thermo Fisher Scientific | 223.49B |
| Abbott Laboratories | 220.95B |